ArticleDiscover oncology2025

Upregulation of CD19 by low-dose chidamide promotes CAR T cells functionality in B-cell non-Hodgkin lymphoma.

Ying Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.